By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Adaptimmune Ltd. 

57c Milton Park

Abingdon  Oxfordshire  OX14 4RX  United Kingdom
Phone: +44-(0)-1235-438-642 Fax: +44-(0)-1235-438-607


Company News
Adaptimmune To Participate In The Wedbush 2015 Life Sciences Conference 8/4/2015 10:26:10 AM
Adaptimmune’s NY-ESO-1 TCR-Engineered T-Cells Demonstrate Durable Persistence, Clinical Activity And Tolerability In Clinical Study In Multiple Myeloma Patients 7/20/2015 1:03:38 PM
Adaptimmune Announces FDA Acceptance Of Investigational New Drug (IND) Application For MAGE-A10 T In Patients With Non-Small Cell Lung Cancer 7/2/2015 7:26:07 AM
ASCO15: Adaptimmune Announces Data From Clinical Studies Of NY-ESO-1 Specific T-Cells In Multiple Cancers At The 2015 Annual ASCO Meeting 6/1/2015 7:29:24 AM
Adaptimmune Announces New Additions To Senior Clinical Management 5/20/2015 2:10:37 PM
Citi Appointed Depositary Bank For Adaptimmune’s ADR Programme 5/19/2015 1:11:40 PM
Adaptimmune Announces Upcoming Data Presentation At The 2015 Annual American Society Of Gene And Cell Therapy (ASGCT) Meeting 5/13/2015 12:52:00 PM
Adaptimmune Announces Appointment Of Vice President Of Investor Relations 5/13/2015 7:34:23 AM
Adaptimmune Announces Closing Of IPO 5/11/2015 10:24:13 AM
Adaptimmune Announces Pricing Of IPO 5/6/2015 10:59:12 AM